-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MqRUlT03herpJejgvb0icqZRkBKpp8THp1xwUrBi8NjU0+dDFAHs/lzAo/DdCS2e WukfvUyMPY63sEI2IvbGmQ== 0001140361-10-043899.txt : 20101105 0001140361-10-043899.hdr.sgml : 20101105 20101105150142 ACCESSION NUMBER: 0001140361-10-043899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101103 FILED AS OF DATE: 20101105 DATE AS OF CHANGE: 20101105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAFFI ROBERT CENTRAL INDEX KEY: 0001274826 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 101168293 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0303 4 2010-11-03 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001274826 BAFFI ROBERT C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Technical Operations Common Stock 2010-10-29 2010-10-29 5 A 0 473 11.637 A 69713 D Common Stock 2010-11-03 2010-11-03 4 S 0 2000 25.244 D 67713 D The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of May 1, 2010 to October 29, 2010. In accordance with ESPP, these shares have been purchased at 85% of the closing price of issuer's common stock on April 30, 2010. The price in Column 4 is a weighted average price. The prices actually received range from $25.24 to $25.251. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. /s/ Laura Randall Woodhead, Attorney-in-Fact 2010-11-05 -----END PRIVACY-ENHANCED MESSAGE-----